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Background: Weight loss and undernutrition are common in patients with Alzheimer’s disease (AD) 
and associated with negative health outcomes. In the current guidelines on diagnosis and treatment 
of AD, no recommendations for treatment of (risk of ) undernutrition in community-dwelling AD 
patients are given.
Methods: We conducted a systematic review on the effect of nutritional interventions in community-
dwelling AD patients with (risk of ) undernutrition, according to the methods outlined by the 
Cochrane Collaboration. Three electronic databases and three trial registers were searched from 
inception till April 2013. 
Results: Literature search in the electronic databases yielded 546 records of which one was relevant 
for this review. This study, with a high risk of bias, demonstrated that oral nutritional supplements 
improved nutritional outcomes without effect on clinical and biochemical outcomes. The search in 
the trial registers yielded 369 records of which two were relevant. One trial was terminated because 
of failing inclusion, the other is ongoing. 
Conclusion: This systematic review on the effect of nutritional interventions in community-dwelling 
AD patients with (risk of ) undernutrition, reveals a serious lack of evidence. Therefore, it is not 
possible to state what the best approach is.
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IntRoductIon
In 1907, Alois Alzheimer described weight loss in his first patient1 and weight loss is currently 
recognized as a clinical feature of AD2. Weight loss, a characteristic of undernutrition3, has been 
described in approximately 20% to 45% of community-dwelling AD patients4-9. In our own recent 
publication, one in seven community-dwelling elderly with newly diagnosed AD was at risk of 
undernutrition according to the Mini Nutritional Assessment (MNA)10. Other studies in community-
dwelling AD patients reported even higher rates of prevalence of at risk of undernutrition (evaluated 
with the MNA), ranging from 26% to 80%8,11-17. Weight loss and (risk of ) undernutrition have been 
associated with an accelerated progression of AD6,7,12,18, a higher rate of institutionalization19 and 
increased mortality20-22. 
Thus, the prevalence of weight loss and risk of undernutrition in community-dwelling AD 
patients is high and associated with negative health outcomes. Nevertheless, in the current 
guidelines on diagnosis and treatment of AD23-25, no attention is given to what clinicians should do 
in case of poor nutritional status in community-dwelling AD patients. There are several guidelines 
and studies on the treatment of (risk of ) undernutrition in older people without AD26,27. However, in 
our opinion, these results can not be extrapolated to AD patients. Firstly, because the mechanism 
of weight loss and undernutrition in AD patients is probably not the same as in individuals without 
AD. This is supported by studies showing that the prevalence of weight loss is higher in patients with 
AD compared to controls without AD4,5,28. Secondly, because of expected differences in adherence 
to the nutritional interventions. Due to their cognitive impairment, AD patients may forget to take 
an oral nutritional supplement (ONS).  
Given the adverse outcomes of weight loss and (risk of ) undernutrition, there is a need 
for evidence-based nutritional interventions for community-dwelling AD patients with a poor 
nutritional status. A systematic review (type 1 in the hierarchy of evidence) is considered the best 
way of assessing the evidence base for interventions29. We conducted a systematic review with 
the aim to critically assess the current evidence regarding the effect of nutritional interventions in 
community-dwelling AD patients with (risk of ) undernutrition. 
Methods 
This systematic review was conducted according to the methods outlined by the Cochrane 
Collaboration29.
Review question and eligibility criteria
We defined eligibility criteria based on the PICO framework29 and types of studies (table 1). Our 
PICO was: what is the effect of nutritional interventions (I) in community-dwelling AD patients with 
(risk of ) undernutrition (P) compared to an inactive or active control intervention  (C) on clinical, 
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nutritional and economic outcomes (O)? Studies were eligible for inclusion if they met the pre-
determined inclusion criteria (table 1). Although their evidence is less robust, non-randomized 
controlled trials (RCTs) were included to ensure capture of all of the available information. Studies in 
all languages were included to prevent bias29. There were no restrictions with regard to publication 
year.
Table 1. Inclusion and exclusion criteria for selection of studies based on the PICO framework and 
study types
Inclusion criteria Exclusion criteria
Participants
	Probable Alzheimer’s disease 
according to accepted criteria such 
as the NINCDS-ADRDA (2)
	Community-dwelling 
	Undernourished or at risk of 
undernutrition according to 
accepted criteria such as the MNA59
	Patients without Alzheimer ’s disease




	Nutritional intervention, i.e. any 
intervention provided with the aim 
to improve nutritional status (e.g. 
weight, upper arm anthropometry), 
such as oral nutritional 
supplements, dietary advice, food 
fortification, nutritional education 
programs
	Studies using specially designed 
supplements or supplements containing 
only specific amino acids or micronutrients, 
not given with the aim to improve 
nutritional status but, for example, to 
influence specific brain processes
Comparison
	Inactive control intervention 
(e.g. placebo, no treatment, care 
as usual), or an active control 
intervention (e.g. a different kind 




	Clinical outcomes (e.g.  mortality, 
cognitive 
    function, functional status, behavior, 
quality of live) 
	Nutritional outcomes (e.g. weight, 
upper arm 





	RCTs, non-RCTs 	Case reports, retrospective observational 
studies
Abbreviations: PICO: Population, Intervention, Comparison, Outcomes, NINCDS-ADRDA: National Institute 
of Neurological and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related 
Disorders Association, MNA: Mini Nutritional Assessment, RCT: Randomized Controlled Trial
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Search methods
Assisted by information specialists, three electronic databases, including Pubmed, Embase and 
the Cochrane Central Register of Controlled Trials, were searched from inception till April 24 
2013. In addition, three trial registers, including Clinicaltrials.gov (an American trial register), 
Clinicaltrialregister.eu (an European trial register) and Trialregister.nl (a Dutch trial register) were 
searched in order to identify unpublished trials. Search terms (Medical Subject Headings (MeSH), 
Emtree, keywords and title and abstract words) for Alzheimer’s disease, undernourished or at risk 
of undernutrition and nutritional intervention were combined (table 2). Initially, we combined the 
terms with search terms for community-dwelling. Though, this search provided only 10 records. 
Data selection and data extraction
Studies were selected based on eligibility criteria (table 1) in two steps. The first step involved 
screening of the studies by title and abstract. Potential relevant studies identified in the first step, 
were subsequently assessed for eligibility based on the full-text. If necessary, authors of studies 
were contacted to obtain information. The data selection was done independently by two reviewers 
(ED and DA). The agreement between the two reviewers was measured by calculating the kappa 
value29. Data of eligible studies were extracted by one reviewer (ED) and confirmed independently 
by the other reviewer (DA). 
Assessment of risk of bias 
Two investigators independently (ED and DA) assessed the risk of bias of the included studies 
following the instructions given in the Cochrane handbook29. This handbook recommends assessing 
the risk of bias for seven domains. Each domain was judged by categorizing it as low, high or unclear 
risk of bias29. 
Quality assessment
We planned to assess the quality of evidence for each outcome using the Grades of Recommendation, 
Assessment, Development and Evaluation Working Group (GRADE) system29-31. Quality assessment 
was performed if there were at least two studies on the same intervention and on the same outcome, 
because consistency (i.e. the degree of heterogeneity) of results cannot be assessed with only one 
study. The quality assessment was planned to be done by two reviewers, independently.
Data analysis 
We planned to perform a meta-analysis according to the recommendations of the Cochrane 
Collaboration29. Heterogeneity would be explored by the X2 test and with I2 statistics. If a meta-
analysis was not suitable, we planned to perform a narrative analysis. 
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Table 2. Search terms used in Pubmed
Alzheimer’s disease (“Alzheimer Disease”[Mesh] OR alzheimer*[tiab] OR senile dementia*[tiab] OR 
presenile dementia*[tiab] OR pre senile dementia*[tiab])
Undernourished or 
at risk of 
undernutrition
(must[tiab] OR snaq[tiab] OR simplified nutritional appetite questionnaire[tiab] OR 
appetite assessment[tiab] OR nutrition screening[tiab] OR nutritional screening[tiab] 
OR (nsi[tiab] AND nutrition*[tiab]) OR (ansi[tiab] AND nutrition*[tiab]) OR SCREEN 
I[tiab] OR SCREEN II[tiab] OR nutritional risk*[tiab] OR nutrition risk*[tiab] OR 
mna[tiab] OR “Nutrition Assessment”[Mesh] OR nutrition assessment*[tiab] OR 
nutritional assessment*[tiab] OR nutritional index*[tiab] OR nutrition indice*[tiab] 
OR nutritional indice*[tiab] OR nutritional survey*[tiab] OR nutrition survey*[tiab] 
OR diet survey*[tiab] OR dietary survey*[tiab] OR pni[tiab] OR “Malnutrition”[Mesh] 
OR protein deficiency[tiab] OR malnutrition*[tiab] OR malnourish*[tiab] OR 
undernutrition*[tiab] OR under nutrition*[tiab] OR undernourish*[tiab] OR nutritional 
deficienc*[tiab] OR nutrition deficienc*[tiab] OR “Body Weight”[Mesh:noexp] 
OR “Weight Loss”[Mesh] OR weight loss*[tiab] OR weight reduction*[tiab] OR 
“Thinness”[Mesh] OR thinness*[tiab] OR underweight*[tiab] OR under weight*[tiab] 
OR nutritional disorder*[tiab] OR nutrition disorder*[tiab] OR “Nutrition 
Disorders”[Mesh:noexp] OR desnutrition*[tiab] OR “Nutritional Status”[Mesh] OR 
nutritional status*[tiab])     
Nutritional 
intervention
(“Dietary Supplements”[Mesh] OR dietary supplement*[tiab] OR dietary 
additive*[tiab] OR diet supplement*[tiab] OR nutraceutic*[tiab] OR food 
supplement*[tiab] OR supplemented food*[tiab] OR nutritional supplement*[tiab] 
OR nutrition supplement*[tiab] OR ons[tiab] OR sip feed*[tiab] OR sipfeed*[tiab] 
OR “Dietary Services”[Mesh] OR dietary service*[tiab] OR nutritional program*[tiab] 
OR nutrition program*[tiab] OR dietary fortification*[tiab] OR diet fortification[tiab] 
OR food fortification[tiab] OR dietary counseling[tiab] OR diet counseling[tiab] OR 
nutritional support[tiab] OR nutrition support[tiab] OR nutritional care[tiab] OR 
nutrition care[tiab] OR nutritional intervention*[tiab] OR nutrition intervention*[tiab] 
OR nutritional treatment*[tiab] OR nutrition treatment*[tiab] OR nutritional 
management[tiab] OR nutrition management[tiab] OR “Nutrition Therapy”[Mesh] OR 
nutrition therap*[tiab] OR nutritional therap*[tiab] OR “diet therapy”[Subheading] 
OR diet therap*[tiab] OR dietary management[tiab] OR diet manag*[tiab] OR 
diet advice*[tiab] OR dietary advice*[tiab] OR “Food, Fortified”[Mesh] OR fortified 
food*[tiab] OR enriched food*[tiab] OR nutrition education[tiab] OR food 
education[tiab] OR diet education[tiab] OR nutritional education[tiab] OR dietary 
education[tiab] OR “Health Education”[Mesh] OR “Elder Nutritional Physiological  
Phenomena”[Mesh])
The search may be reproduced by adding the boolean operator AND in between the different search sets.
Abbreviations: MUST: Malnutrition Universal Screening Tool, SNAQ: Simplified Nutritional Appetite 
Questionnaire, NSI: Nutrition Screening Initiative, ANSI: Australian Nutritional Screening Initiative, SCREEN: 
Seniors in the Community; Risk Evaluation for Eating and Nutrition, MNA: Mini Nutritional Assessment 
(the MUST, SNAQ, NSI, ANSI, SCREEN and MNA are nutrition screening tools for older adults living in the 
community), PNI: Prognostic Nutritional Index , ONS: Oral Nutritional Supplements, MeSH: Medical Subject 
Headings, tiab: title and abstract, noexp: Do not include MeSH terms found below this term in the MeSH 
hierarchy  
* Truncation was used to find word variants. For example: a search for alzheimer* finds citations with the 
word alzheimers. 
N.a. 1: The search terms in Embase and the Cochrane Central Register of Controlled Trials were derived from 
the search terms used in Pubmed and are available on request from the author. 
N.a.2: In the trial registers the following search terms were used: alzheimer, senile dementia, presenile 
dementia, pre senile dementia, dementia, nutritional treatment, nutrition treatment, nutritional 
management, nutrition therapy, nutritional therapy, dietary management, diet advice, dietary advice, 
fortified food, enriched food, nutrition education, food education, diet education, nutritional education, 
dietary education, health education
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Results
Results of the search
Literature search yielded 546 records. After removal of duplicates, 473 studies remained for 
screening of title and abstract after which 451 were excluded. The full-text of three articles could 
not be obtained, leaving 19 articles for full-text review. Of these, six were excluded because the 
study participants were not undernourished or at risk of undernutrition32-37. Three were excluded 
because the participants were not community-dwelling38-40. Another five studies were excluded 
because it involved a description of a study protocol41-45 and four studies were excluded because 
of other reasons (see figure 1)6,46-48, leaving one study relevant for the purpose of this review49. The 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart in figure 1 
outlines the study selection process50. The agreement between the two reviewers with regard to the 
data selection was fair (i.e. a kappa value of 0.49)29. 
The search in the trial registers yielded 369 records, of which 207 were found in the American 
trial register, 134 in the European trial register and 28 in the Dutch trial register. After screening of 
the titles and the abstracts, two trials were considered relevant51,52.
Table 3. Assessment of risk of bias
Domain Judgement Support for judgement
Random sequence 
generation
Low risk The investigators describe a random component in the 
sequence generation process: the subjects were randomized 
into two groups by drawing numbers with sealed envelopes.
Allocation concealment High risk It is not stated whether the envelopes were sequentially 
numbered or whether they were opaque.
Blinding of participants 
and personnel 
High risk No placebo was used, so participants were not be blinded for 
the intervention. In addition, the dietician was not blinded 
which may have influenced the outcomes.
Blinding of outcome 
assessment
High risk The outcome measurement is potentially to be influenced by 
lack of blinding of the dietician.
Incomplete outcome 
data
High risk In the intervention group, two participants died and seven 
were excluded (i.e. 20% of the patients from the intervention 
group dropped out after three months). In the control group, 
only two patients were excluded after three months (i.e. this is 
a drop-out rate of 4%). This imbalance may have influenced the 
outcomes. 
Selective reporting High risk Not all of the study’s pre-specified outcomes have been 
reported, for example compliance of the oral nutritional 
supplements. 
Other bias Unclear There is insufficient information to assess whether an 
important other risk of bias exist.
Assessed study: Lauque et al., 200449
N.a.: Each domain was judged by categorizing it as ‘low risk of bias’ (i.e. plausible bias unlikely to seriously 
alter the results), ‘high risk of bias’ (i.e. plausible bias that seriously weakens confidence in the results) or 




The study relevant for the present review is the study of Lauque et al., published in 200449. It was a 
prospective, randomized, controlled study on the effect of ONS on clinical (cognition, Activities of 
Daily Living (ADL), fractures, pressure ulcers, hospitalization), nutritional (weight, Body Mass Index 
(BMI), MNA, eating behavior, energy intake, protein intake, fat-free mass) and biochemical (albumin, 
C-reactive protein) outcomes in community-dwelling AD patients at risk of undernutrition, as 
evaluated with the MNA. The ONS used contained between 300 and 500 kcal in addition to the 
patients’ spontaneous food intake and was enriched with proteins, vitamins and minerals. 46 Patients 
received three months ONS (intervention group) and 45 patients received care as usual (control 
group). Three months daily ONS significantly improved nutritional outcomes in the intervention 
group. The nutritional status of the control group also improved after three months. Although, the 
intervention group improved significantly more than the control group. No significant changes 
were found on the clinical and biochemical outcomes49. 
Two trials were considered relevant for the purpose of the present review. One trial, still ongoing, 

























Records identiﬁed through database searching 
n = 546 
Records after removal of duplicates 
n = 473 
Records screened by 
title and abstract 
n = 473 
Records excluded 
n = 451 
Full-text articles 
assessed for eligibility 
n = 19 
Full-text articles 
excluded  
n = 18 
Main reasons for exclusion: 
 Not undernourished or at risk 
of undernutrition: n = 6 
 Not community-dwelling: n = 3 
 Description of a study protocol: 
n = 5 
 Other reason(s)*: n = 4 
Studies included  
n = 1 
3 Full-text articles could 
not be obtained 
* Other reason(s): no nutritional intervention was applied (6), a systematic review on 
interventions on mealtime diﬃculties in dementia (not speciﬁcally Alzheimer’s disease 
(AD)) (48), a systematic review on the eﬀect of nutritional interventions in elderly people 
(not speciﬁcally AD) (46), a poster presentation of a qualitative study on tailored 
nutritional advice in AD patients (47). 
Figure 1. PRISMA flowchart representing the study selection proces
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for patients with neurodegenerative diseases and related malnutrition) in patients with senile 
dementia at risk of malnutrition. It is not clear if the patients are community-dwelling51. The other 
trial aimed to evaluate the effect of megestrol acetate in outpatients with dementia and weight 
loss52. This trial was prematurely terminated because of insufficient recruitment.     
Risk of bias 
The outcome of the assessment of risk of bias in the study of Lauque et al. (2004)49 is presented in 
table 3. The overall risk of bias was judged as ‘high’, because five of the seven domains were judged 
as ‘high risk of bias’ (table 3). 
Quality assessment and data analysis
It was not possible to perform a quality assessment or meta-analysis, because only one study was 
included.
dIscussIon
This is the first systematic review on the effect of nutritional interventions in community-dwelling 
AD patients with (risk of ) undernutrition. Surprisingly, only one study was eligible for the purpose of 
this review. In this study, Lauque et al. showed that ONS significantly improved nutritional outcomes 
in community-dwelling AD patients at risk of undernutrition49. However, no effect was found on 
clinical and biochemical outcomes49. In addition, the risk of bias in the study of Lauque et al. was 
high. What does the lack of evidence mean? 
It may mean that undernutrition in community-dwelling AD patients is not such an important 
issue as postulated. This is supported by the fact that one of the retrieved trials in the present 
systematic review was terminated because of difficulties in the recruitment of patients meeting the 
inclusion criteria, including undernutrition52. In addition, a recent study showed that community-
dwelling patients with moderate AD did not lose weight during four years of follow-up53. Moreover, 
in our own recent published investigation, the prevalence of undernutrition in community-dwelling, 
newly diagnosed AD patients was 0%10. This low number of undernourished patients is in line with 
other studies, where the prevalence of undernutrition in community-dwelling AD patients ranged 
from 0% to 9% (as evaluated with the MNA)15,17,18. 
Although, frank undernutrition may be a non-issue in community-dwelling AD patients, one 
in seven community-dwelling elderly with newly diagnosed AD was at risk of undernutrition in 
our recent published investigation10 and other studies reported even higher rates, ranging from 
26% tot 80%8,11-17. Given the adverse outcomes of weight loss and (risk of ) undernutrition, it is 
important to know what the best approach is to community-dwelling AD patients with a risk of 
developping a poor nutritional status. Unfortunately, based on the results of the present systematic 
review, it is not possible to state what the best approach is. Several studies investigated the effect 
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of nutritional interventions in institutionalized patients with an advanced stage of dementia54-56. 
However, these results can not be extrapolated to community-dwelling AD patients, because for 
example the compliance in institutionalized patients may be better than in community-dwelling 
patients, i.e. community-dwelling patients have no professional caregiver who ensures that the 
patient is adherent to therapy. More research is needed to be conclusive about the best approach to 
community-dwelling AD patients with risk of undernutrition. In addition, research should focus on 
establishing its risk factors in order to design targeted (nutritional) interventions. Moreover, future 
trials should focus on outcomes of relevance to patients and caregivers, such as improvements in 
function and quality of life. 
Another explanation for the lack of evidence may be our strict eligibility criteria. However, we 
have consciously chosen for these criteria. We focused on community-dwelling AD patients because 
most of the AD patients are community-dwelling (i.e. in the Netherlands for example 70%)57. 
Moreover, by focussing on community-dwelling patients, it is possible to figure out if a nutritional 
intervention can delay institutionalisation. We focused on patients with a poor nutritional status 
because they benefit the most from nutritional interventions58. 
Unfortunately, despite our comprehensive literature search, only one study was relevant for 
the purpose of this review. Hence, it was not possible to perform a meta-analysis and to give firm 
conclusions about the effect of nutritional interventions in community-dwelling AD patients with 
(risk of ) undernutrition. A strength of the present study is that the data selection was done by two 
reviewers, independently. The agreement between the two reviewers was fair. Another strength 
includes that studies in all languages were retrieved. Moreover, three trial registers were searched. 
In conclusion, the present systematic review on the effect of nutritional interventions in 
community-dwelling AD patients with (risk of ) undernutrition, reveals a serious lack of evidence. As 
a result, it is not possible to state what the beste approach is. Frank undernutrition in community-
dwelling AD patients appears to be an infrequent condition. Many patients however are at risk of 
undernutrition. Therefore, research should focus on establishing its risk factors in order to design 
targeted (nutritional) interventions.    
107
 Nutritional interventions in community-dwelling Alzheimer patients with (risk of) undernutrition: a systematic review
3
RefeRences
1. Inelmen, E.M., Sergi, G., Coin, A., Girardi, A. and Manzato, E. (2010). An open-ended question: Alzheimer’s 
disease and involuntary weight loss: which comes first? Aging Clinical Experimental Research, 2010, 22, 192-
197. doi: 10.3275/6677.
2. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. (1984). Clinical diagnosis 
of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of 
Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34, 189-198.
3. Van Asselt, D.Z. et al. (2012). Assessment and treatment of malnutrition in Dutch geriatric practice: 
consensus through a modified Delphi study. Age and Ageing, 41, 399-404. doi: 10.1093/ageing/afs005.
4. Wolf-Klein, G.P., Silverstone, F.A. and Levy, A.P. (1992). Nutritional patterns and weight change in Alzheimer 
patients. International Psychogeriatrics, 4, 103-118.
5. White, H., Pieper, C., Schmader, K. and Fillenbaum G. (1996). Weight change in Alzheimer’s disease. Journal 
of the American Geriatrics Society, 44, 265-272.
6. Gillette-Guyonnet, S. et al. (2000). Weight loss in Alzheimer disease. The American Journal of  Clinical 
Nutrition, 71, 637-642. 
7. Gillette-Guyonnet, S., Cortes, F. and Vellas, B. (2005). Long-term cholinergic treatment is not associated with 
greater risk of weight loss during Alzheimer’s disease: data from the French Real. Fr. Cohort. The Journal of 
Nutrition, Health, and Aging, 9, 69-73. 
8. Guérin, O. et al. (2005a). Different modes of weight loss in Alzheimer disease: a prospective study of 395 
patients. The American Journal of Clinical Nutrition, 82, 435-441.
9. Besser, L.M. et al. (2014). Body Mass Index, weight change, and clinical progression in mild cognitive 
impairment and Alzheimer Disease. Alzheimer Disease and Associated Disorders, 28, 36-43. doi: 10.1097/
WAD.0000000000000005.
10. Droogsma, E., Van Asselt, D.Z., Schölzel-Dorenbos, C.J., Van Steijn, J.H., Van Walderveen, P.E. and Van der 
Hooft, C.S. (2013). Nutritional status of community-dwelling elderly with newly diagnosed Alzheimer’s 
disease: prevalence of malnutrition and the relation of various factors to nutritional status. The Journal of 
Nutrition, Health, and Aging, 17, 606-610. doi: 10.1007/s12603-013-0032-9.
11. Nourhashemi, F., Amouyal-Barkate, K., Gillette-Guyonnet, S., Cantet, C. and Vellas B. (2005). Living alone 
with Alzheimer’s disease: cross-sectional and longitudinal analysis in the real.fr study. The Journal of 
Nutrition, Health, and Aging, 9, 117-120. 
12. Vellas, B. et al. (2005). Impact of nutritional status on the evolution of Alzheimer’s disease and on response 
to acetylcholinesterase inhibitor treatment. The Journal of Nutrition, Health, and Aging, 9,  75-80.
13. Ousset, P.J., Nourhashemi, F., Reynish, E. and Vellas, B. (2008). Nutritional status is associated with disease 
progression in very mild Alzheimer disease. Alzheimer Disease and Associated Disorders, 22, 66-71. doi: 
10.1097/WAD.0b013e31815a9dbb.
14. Gillioz, A.S. et al. (2009). Spared and Impaired Abilities in Community-Dwelling Patients Entering the 
Severe Stage of Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders, 28, 427-432. doi: 
10.1159/000255635.
15. Scheltens ,P. (2009). Moving forward with nutrition in Alzheimer’s disease. European Journal of Neurology, 
16, 19-22. doi: 10.1111/j.1468-1331.2009.02738.x.
16. Spaccavento, S., Del Prete, M., Craca, A. and Fiore P. (2009) Influence of nutritional status on cognitive, 




17. Saragat, B. et al. (2012). Nutritional and psycho-functional status in elderly patients with Alzheimer’s 
disease. The Journal of Nutrition, Health, and Aging, 16, 231-236.
18. Guérin, O., Soto, M.E., Brocker, P., Robert, P.H., Benoit, M. and Vellas, B. (2005b). Nutritional status assessment 
during Alzheimer’s disease: results after one year (the real French study Group). The Journal of Nutrition, 
Health, and Aging, 9, 81-84. 
19. Andrieu, S. et al. (2001). Nutritional risk factors for institutional placement in Alzheimer’s disease after one 
year follow-up. The Journal of Nutrition, Health, and Aging, 5, 113-117.  
20. White, H., Pieper, C. and Schmader K. (1998). The association of weight change in Alzheimer’s disease with 
severity of disease and mortality: A longitudinal analysis. Journal of the American Geriatrics Society, 46, 1223-
1227.  
21. Gambassi, G., Landi, F., Lapane K.L., Sgadari, A., Mor, V. and Bernabei, R. (1999). Predictors of mortality 
in patients with Alzheimer’s disease living in nursing homes. Journal of Neurology, Neurosurgergy, and 
Psychiatry, 67, 59-65.
22. Faxen-Irving, G., Basun, H. and Cederholm, T. (2005). Nutritional and cognitive relationships and long-term 
mortality in patients with various dementia disorders. Age and Ageing, 34, 136-141.
23. Scottish Intercollegiate Guidelines Network. (2006). Management of patients with dementia: a national 
clinical guideline. Edinburgh. Available at: http://www.sign.ac.uk/pdf/sign86.pdf; last accessed 6 March 
2014.
24. Ministry of Health Singapore. (2007). Clinical Practice Guideline: dementia. Available at: http://www.moh.
gov.sg/content/dam/moh_web/HPP/Doctors/cpg_medical/current/2007/CPG_Dementia_Booklet.pdf; 
last accessed 6 March 2014.
25. Hort, J. et al. (2010). EFNS guidelines for the diagnosis and management of Alzheimer’s disease. Journal of 
Neurology, 17, 1236-1248. doi: 10.1111/j.1468-1331.2010.03040.x.
26. Volkert, D. et al. (2006). ESPEN Guidelines on enteral nutrition: geriatrics. Clinical Nutrition, 25, 330-360. 
American Dietetic Association. (2009). Unintended weight loss (UWL) in older adults evidence-based 
nutrition practice guideline. Chicago. Available at: http://andevidencelibrary.com/topic.cfm?cat=3653; last 
accessed 6 March 2014.
27. Barret-Connor, E., Edelstein, S.L., Corey-Bloom, J. and Wiederholt, W.C. (1996). Weight loss precedes 
dementia in community-dwelling older adults. Journal of the American Geriatrics Society, 44, 1147-1152.
28. Higgins, J.P.T. and Green, S. (2011). Cochrane Handbook for Systematic Reviews of Interventions 
29. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, Available from www.cochrane-handbook.
org.
30. Atkins, D. et al. (2004). Grading quality of evidence and strength of recommendations. British Medical 
Journal, 328, 1490-1494.
31. Guyatt, G.H. et al. (2008). GRADE: an emerging consensus on rating quality of evidence and strength of 
recommendations. British Medical Journal, 336, 924-926. doi: 10.1136/bmj.39489.470347.AD.
32. Rivière, S. et al. (2001) A nutritional education program could prevent weight loss and slow cognitive 
decline in Alzheimer’s disease. The Journal of Nutrition, Health, and Aging, 5, 295-299.
33. Planas, M. et al. (2004). Micronutrient supplementation in mild Alzheimer disease patients. Clinical Nutrition, 
23, 265-272.
34. Shatenstein, B., Kergoat, M., Reid, I. and Chicoine, M.E. (2008). Dietary intervention in older adults with early-
stage Alzheimer dementia: early lessons learned. The Journal of Nutrition, Health, and Aging, 12, 461-469.
109
 Nutritional interventions in community-dwelling Alzheimer patients with (risk of) undernutrition: a systematic review
3
35. Faxén Irving, G. et al. (2009). Omega-3 Fatty acid supplementation effects on weight and appetite in 
patients with Alzheimer’s disease: the omega-3 Alzheimer’s disease study. Journal of the American Geriatrics 
Society, 57, 11-17. doi: 10.1111/j.1532-5415.2008.02055
36. Salva, A. et al. (2011). Health and nutritional promotion program for patients with dementia (NUTRIALZ 
Study): cluster randomized trial. The Journal of Nutrition, Health, and Aging, 15, 822-830.
37. Pivi, G.A. et al. (2011). A prospective study of nutrition education and oral nutritional supplementation in 
patients with Alzheimer’s disease. Nutrition Journal, 10, 98. doi: 10.1186/1475-2891-10-98.
38. Salas-Salvadó, J. et al. (2005). Effect of oral administration of a whole formula diet on nutritional and 
cognitive status in patients with Alzheimer’s disease. Clinical Nutrition, 24, 390-397.
39. Navratilova, M., Jarkovsky, J., Ceβkova, B., Leonard, B. and Sobotkas, L. (2007). Alzheimer disease: 
malnutrition and nutritional support. Clinical and Experimental Pharmacology and Physiology, 34, 11-13. doi: 
10.1111/j.1440-1681.2007.04761.x
40. De Sousa, O.L.V. and Amaral, T.F. (2012). Three-week nutritional supplementation effect on long-term 
nutritional status of patients with Alzheimer disease. Alzheimer Disease and Associated Disorders, 26, 119-
123. doi: 10.1097/WAD.0b013e31822c5bb3.
41. Rivière, S., Lauque, S. and Vellas, B. (1998). Health promotion programme: nutrition and Alzheimer’s disease. 
The Journal of Nutrition, Health, and Aging, 2, 101-106. 
42. Rivière, S., Gillette-Guyonnet, S., Nourhashemi, F. and Vellas, B. (1999). Nutrition and Alzheimer’s disease. 
Nutrition reviews, 57, 363-367. 
43. George, D.R., Dangour, A.D., Smith, L., Ruddick, J., Vellas, B. and Whitehouse, P.J. (2009). The role of nutrients 
in the prevention and treatment of Alzheimer’s disease: methodology for a systematic review. European 
Journal of Neurology, 16, 8-11. doi: 10.1111/j.1468-1331.2009.02736.x.
44. Salva, A. et al. (2009). Health and nutritional promotion program for patients with dementia (NUTRIALZ 
Study): design and baseline data. The Journal of Nutrition, Health, and Aging, 13, 529-537.
45. Jyvakorpi, S.K., Puranen, T., Pitkala, K.H. and Suominen, M.H. (2012). Nutritional treatment of aged 
individuals with Alzheimer disease living at home with their spouses: study protocol for a randomized 
controlled trial. Trials, 13:66. doi: 10.1186/1745-6215-13-66.
46. Milne, A.D., Potter, J., Vivani, A. and Avenell, A. (2009). Protein and energy supplementation in elderly 
people at risk from malnutrition. Cochrane Database of Systematic Reviews (Online), (2), CD003288. doi: 
10.1002/14651858.CD003288.
47. Puranen, T., Jyvakorpi, S., Eloniemi-Sulkava, U. and Suominen, M. (2012). How to improve nutrient intake of 
Alzheimer’s patients living at home with their spouses – qualitative description of tailored nutritional advice. 
Poster presentation, available at:  http://download.journals.elsevierhealth.com/pdfs/journals/1744-1161/
PIIS1744116112701035.pdf; last accessed 6 March 2014.
48. Liu, W., Cheon, J. and Thomas, S.A. (2014). Interventions on mealtime difficulties in older adults with 
dementia: a systematic review. International Journal of Nursing Studies, 51, 14-27. doi: 10.1016/j.
ijnurstu.2012.12.021 
49. Lauque, S. et al. (2004). Improvement of weight and fat-free mass with oral nutritional supplementation 
in patients with Alzheimer’s disease at risk of malnutrition: a prospective randomized study. Journal of the 
American Geriatrics Society, 52, 1702-1707. 
50. Liberati, A. et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of 




51. Clinicaltrials.gov.-a (2012). Evaluation of a Diet in Patients With Senile Dementia. Available at: http://
ClinicalTrials.gov/show/NCT01192529; last accessed 6 March 2014.
52. Clinicaltrials.gov.-b (2011). Study to Evaluate the Effect of Megestrol Acetate in Weight Loss in Dementia 
Patients. Available at: http://clinicaltrials.gov/show/NCT00503516; last accessed 6 March 2014.
53. Secher, M. et al. (2013). Weight changes in Alzheimer’s disease patients with increased aberrant motor 
behavior. International Journal of Geriatric Psychiatry, 28, 998-1004. doi: 10.1002/gps.3914.
54. Wouters-Wesseling, W., Wouters, A.E., Kleijer, C.N., Bindels, J.G., De Groot, C.P. and Van Staveren, W.A. (2002). 
Study of the effect of a liquid nutrition supplement on the nutritional status of psycho-geriatric nursing 
home patients. European Journal of Clinical Nutrition, 56, 245-251.
55. Gil Gregorio, P., Ramires Diaz, S.P. and Ribera Casado, J.M. (2003). Dementia and nutrition. Intervention study 
in institutionalized patients with Alzheimer disease. The Journal of Nutrition, Health, and Aging, 7, 304-308. 
56. Young, K., Greenwood, C.E., Van Reekum, R. and Binns, M.A. (2004). Providing nutrition supplements to 
institutionalized seniors with probable Alzheimer’s disease is least beneficial to those with low body 
weight status. Journal of the American Geriatrics Society, 52, 1305-1312.
57. World Health Organization. (2012). Dementia: a public health priority. Available at: http://www.who.int/
mental_health/publications/dementia_report_2012/en/; last accessed 6 March 2014.
58. Stratton, R.J. (2000). Summary of a systematic review on oral nutritional supplement use in the community. 
Proceedings of the nutrition society, 59, 469-476.
59. Guigoz, Y. (2006). The Mini Nutritional Assessment (MNA): Review of the literature – What does it tell us? The 
Journal of Nutrition, Health, and Aging, 10, 466-485.
